Vertex Pharmaceuticals (VRTX)

Income Before Tax

$5.27B

TTM · Period ending: · USD

VRTX logo

VRTX Income Before Tax

Latest reported$5.27B
VRTX TTM Pre-Tax Income ($0.00 → $5.27B)
High-resolution chart · PNG

VRTX income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
5,274,900,000
5,165,700,000
4,643,200,000
4,448,700,000
4,374,000,000
-300,200,000
248,500,000
259,600,000
214,700,000
4,767,400,000
4,379,800,000
4,309,000,000
4,306,200,000
4,169,100,000
4,232,400,000
4,026,500,000
3,932,841,000
2,864,241,000
2,730,401,000
2,748,124,000
2,411,254,000
3,280,224,000
3,116,798,000
2,905,125,000
2,229,920,000
1,732,288,000
1,394,919,000
750,466,000
816,311,000
705,764,000
600,241,000
680,186,000
126,505,000
-54,580,000
-15,689,000
-107,825,000
267,311,000
213,784,000
-70,366,000
-168,501,000
-218,953,000
-391,793,000
-559,581,000
-660,346,000
-734,437,000
-702,265,000
-735,514,000
-897,173,000
-860,002,000
-764,824,000
-976,110,000
-716,629,000
-592,335,000
-543,229,000
-12,381,000
279,192,000
484,914,000
324,449,000
60,445,000
-321,328,000
-730,895,000
-756,031,000
-745,206,000
-1,216,412,000
-1,157,020,000
-1,128,311,000
-1,125,712,000
-627,038,000
-607,517,000
-527,541,000
-461,023,000
-409,543,000
-386,532,000
-412,978,000
-397,552,000
-512,419,000
-457,188,000
-417,079,000
-386,438,000
-14,261,000
-42,037,000
-5,367,000
0
-200,758,000
-159,951,000
-163,232,000
-158,950,000
-11,871,000
-59,521,000
-105,180,000
-44,131,000
-122,286,000
-69,317,000
20,611,000
0
-52,976,000
-48,753,000
-60,860,000
-60,860,000
-55,894,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.